دورية أكاديمية
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
| العنوان: | Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group |
|---|---|
| المؤلفون: | Lorusso, D. *, Ferrandina, G., Pignata, S., Ludovisi, M., Viganò, R., Scalone, S., Scollo, P., Breda, E., Pietragalla, A., Scambia, G. |
| المصدر: | In Annals of Oncology January 2010 21(1):61-66 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdp266 |